What is the pathophysiology of female infertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Female infertility is primarily caused by disruptions in the complex reproductive process, with ovulatory disorders, tubal and pelvic pathology, and uterine factors being the main pathophysiological mechanisms. The most common causes of female infertility include ovulatory failure (21%), tubal damage (14%), and unexplained infertility (28%) 1. Ovulatory disorders, such as polycystic ovary syndrome (PCOS), are characterized by hormonal imbalances involving the hypothalamic-pituitary-ovarian axis, preventing regular egg release. PCOS is the leading cause of anovulatory infertility, affecting at least 7% of adult women 1.

Some key factors that contribute to female infertility include:

  • Deterioration of oocyte quality with increasing maternal age
  • Ovulatory disorders, such as PCOS
  • History of salpingitis, such as that caused by chlamydia infection
  • Endometriosis
  • Uterine cavity abnormalities interfering with implantation

Imaging techniques, such as transvaginal ultrasound (TVUS), can be used to diagnose polycystic ovarian morphology (PCOM) in women suspected of having PCOS 1. TVUS is considered reliable for determining ovarian volume and follicle count, with a revised criteria for diagnosing PCOM consisting of 25 follicles that are 2 to 9 mm in diameter, in at least one ovary 1.

The diagnosis and treatment of female infertility depend on the specific pathophysiology identified, and a thorough evaluation is necessary to determine the underlying cause. Treatment approaches range from ovulation induction medications, surgical interventions for structural issues, to assisted reproductive technologies like intrauterine insemination or in vitro fertilization. Age-related fertility decline is significant, as egg quality and quantity diminish after age 35, with accelerated decline after 37 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Pathophysiology of Female Infertility

The pathophysiology of female infertility is complex and multifactorial. Several factors contribute to female infertility, including:

  • Ovulatory disorders: Polycystic ovary syndrome (PCOS) is a common cause of anovulatory infertility, accounting for approximately 70-80% of cases 2. Hyperinsulinemia is a key contributor to anovulation in PCOS, and reducing insulin levels through weight loss or insulin-sensitizing agents can restore ovulation.
  • Tubal damage: Post-infectious tubal damage is a major cause of female infertility, with pelvic inflammatory disease being the most common cause of tubal damage 3.
  • Endometriosis: Endometriosis is a common gynecologic condition that can cause pain and infertility, although the exact mechanisms of its pathogenesis are unknown 3, 4.
  • Uterine anomalies: Congenital or acquired uterine anomalies, such as septate uterus or myomas, can lead to infertility, pregnancy loss, and other obstetric complications 3, 5.
  • Pelvic adhesions: Pelvic adhesions can cause infertility by obstructing the fallopian tubes or interfering with ovulation 5.

Anatomical Causes of Female Infertility

Anatomical causes of female infertility include:

  • Tubal blockage: Tubal blockage can prevent fertilization by blocking the sperm from reaching the egg 3, 5.
  • Mullerian anomalies: Mullerian anomalies, such as unicornuate or bicornuate uterus, can increase the risk of infertility and pregnancy complications 5.
  • Uterine cavity abnormalities: Abnormalities affecting the uterine cavity, such as leiomyomata or endometrial polyps, can interfere with implantation and increase the risk of miscarriage 5.

Treatment Options for Female Infertility

Treatment options for female infertility depend on the underlying cause and may include:

  • Ovulation induction: Medications such as clomiphene citrate or gonadotropins can stimulate ovulation in women with ovulatory disorders 2, 6.
  • Surgery: Surgery may be necessary to repair tubal damage, remove endometriosis, or correct uterine anomalies 3, 6.
  • In vitro fertilization (IVF): IVF may be recommended for women with severe tubal damage, endometriosis, or other causes of infertility that cannot be treated with surgery or ovulation induction 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The management of infertility associated with polycystic ovary syndrome.

Reproductive biology and endocrinology : RB&E, 2003

Research

Anatomical causes of female infertility and their management.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013

Research

Infertility.

American family physician, 2007

Research

Role of female pelvic anatomy in infertility.

Clinical anatomy (New York, N.Y.), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.